Published in:
Open Access
01-12-2011 | Study protocol
Disease management for co-morbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care
Authors:
Corinne H Stoop, Viola RM Spek, Victor JM Pop, François Pouwer
Published in:
BMC Primary Care
|
Issue 1/2011
Login to get access
Abstract
Background
Depression and anxiety are common co-morbid health problems in patients with type 2 diabetes. Both depression and anxiety are associated with poor glycaemic control and increased risk of poor vascular outcomes and higher mortality rates. Results of previous studies have shown that in clinical practice, treatment of depression and anxiety is far from optimal as these symptoms are frequently overlooked and undertreated.
Methods/Design
This randomised controlled trial will examine the effectiveness of a disease management programme treating symptoms of depression and anxiety in primary care patients with Type 2 diabetes. Patients will be randomized on patient level in 1:1 ratio. Random block sizes of 2 and 4 are used. The disease management programme consists of screening, stepped treatment and monitoring of symptoms (n = 80). This will be compared to care as usual (n = 80).
Discussion
The disease management model for co-morbid depression and anxiety in primary care patients with diabetes is expected to result in reduced symptoms of depression and anxiety, improved quality of life, reduced diabetes specific distress and improved glyceamic control, compared to care as usual.